Incidence of impaired glucose tolerance in essential hypertension patients without diabetes mellitus history and with normal fasting glucose

CLINICAL FOCUS ›› 2011, Vol. 26 ›› Issue (10): 833-835.

Previous Articles Next Articles

Incidence of impaired glucose tolerance in essential hypertension patients without diabetes mellitus history and with normal fasting glucose

WANG Jie-ping;WANG Qing;LV Wei-hua;WANG Peng

Online:2011-05-20 Published:2011-05-20

Abstract

CLC Number:

R544.1

WANG Jie-ping;WANG Qing;LV Wei-hua;WANG Peng. Incidence of impaired glucose tolerance in essential hypertension patients without diabetes mellitus history and with normal fasting glucose[J]. CLINICAL FOCUS, 2011, 26(10): 833-835.

Add to citation manager EndNote|Ris|BibTeX

URL: https://huicui.hebmu.edu.cn/EN/

https://huicui.hebmu.edu.cn/EN/Y2011/V26/I10/833

[1]	Liu Yi, Cui Kun, Liu Chang, Zhao Haotian, Li Li, Xue Hongyuan. Correlation between serum secreted frizzled-related protein 5 and early renal damage in patients with essential hypertension [J]. Clinical Focus, 2023, 38(12): 1073-1077.
[2]	Jiang Ji, Zhu Xiaogang, Jiang Shan, Dawa Zhaba, Cen Qiang. Risk factors of proteinuria in hypertensive people living at high altitude for generations [J]. Clinical Focus, 2023, 38(12): 1086-1090.
[3]	Xu Yang, Xue Ling. Influencing factors for mild cognitive impairment in type H hypertension patients combined with type 2 diabetes mellitus [J]. Clinical Focus, 2023, 38(10): 887-892.
[4]	. [J]. Clinical Focus, 2023, 38(2): 181-184.
[5]	. [J]. Clinical Focus, 2023, 38(1): 88-92.
[6]	Yin Yikun, Yin Xunwei, Wang Jialin, Sun Junzhi. Impacts of Tai Chi exercise cycle on blood pressure and cardiovascular risk factors in essential hypertension: a systematic review and meta-analysis [J]. Clinical Focus, 2022, 37(7): 599-606.
[7]	An Qinyan, Jiang Rong, Kang Bin, Du Ming, Zhou Renming, Zhao Hongjuan, Duan Yi, Lu Fei, Liu Jinming. Levels and clinical significance of RDW, NT-proBNP, BigET-1, HMGB1 in patients with idiopathic pulmonary arterial hypertension [J]. Clinical Focus, 2021, 36(11): 1001-1004.
[8]	. [J]. Clinical Focus, 2021, 36(8): 744-748.
[9]	Gong Tao, Hu Yueyuan, Gao Yun, Guo Chang, Shen Huinan, Wang Dongyu. Relationship between H-type hypertension and severity of neurological deficit in early acute cerebral infarction of LAA [J]. Clinical Focus, 2021, 36(7): 612-615.
[10]	. [J]. Clinical Focus, 2021, 36(6): 566-568.
[11]	. [J]. Clinical Focus, 2021, 36(3): 270-276.
[12]	Liu Xiaoteng, Shan Weichao, Hou Ruitian, Lin Jinping, Gao Yu, Jin Fengbiao, Liu Chang. Correlation between serum hypersensitive C-reactive protein, lipoprotein-related phospholipase A₂and senile essential hypertension complicated with type 2 diabetes [J]. Clinical Focus, 2021, 36(1): 25-29.
[13]	Liang Yuling, Li Wenxi, Gu Xuewen. Randomized controlled trial of Tianma Gouteng Decoction and irbesartan in treatment of essential hypertension [J]. Clinical Focus, 2020, 35(12): 1097-1100.
[14]	Quan Feng;Fan Xuemei;Fang Wenlong. Clinical study of systemic lupus erythematosus associated pulmonary hypertension [J]. Clinical Focus, 2015, 30(12): 1402-1.40414e+007.
[15]	Zhu Bin;Wang Yongxia. Correlation between carotid plaque and blood pressure variation in patients with hypertension [J]. Clinical Focus, 2015, 30(12): 1360-1362.

Incidence of impaired glucose tolerance in essential hypertension patients without diabetes mellitus history and with normal fasting glucose

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments